Hayri Kertmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hayri Kertmen has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Caner Ünlüer
University of Health Sciences Türkiye, Ankara Etlik City Hospital, Clinic of Neurosurgery, Ankara, Türkiye
4 shared publications - Muhammed Kizilgul
Department of Endocrinology and Metabolism Ankara Etlik City Hospital Ankara Türkiye
3 shared publications Zeki Sekerci
Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, 1st Neurosurgery Clinic, 06110 Ankara, Turkey
3 shared publications- Bekir Ucan
Department of Endocrinology and Metabolism, Ankara Etlik City Hospital, Ankara, Türkiye
2 shared publications - Bilge Kocer
Department of Neurology, University of Health Sciences, Ankara Etlik City Hospital, Ankara, Turkey
2 shared publications - Bora Gürer
Department of Neurosurgery, İstinye University, Faculty of Medicine, Istanbul, Turkey
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Turkish Journal of Clinical Research in Turkish Journal of Clinical Research
- Vol. 2 (2) , 121-127
Evaluation of the effects of deep brain neurostimulation in parkinson's patients, analysis of MRI images via artificial intelligence and its use for early diagnosis
Aim: This study aimed to evaluate the early diagnostic potential of subthalamic nucleus (STN) radiomic features and machine learning algorithms to differentiate Parkinson's disease patients requiring Deep Brain Stimulation (DBS) from those managed solely with medical therapy. This approach seeks to provide a non-invasive imaging biomarker to assist in objective surgical decision-making. Methods: A retrospective analysis of 394 Parkinson’s disease patients (200 in the DBS surgical cohort and 194 in the medical treatment cohort) was conducted using preoperative MRI scans. Following meticulous manual segmentation of the STN, a comprehensive set of radiomic features—including shape, first-order statistics, and Gray Level Co-occurrence Matrix (GLCM) parameters—was extracted. A Random Forest classifier was trained on 70% of the dataset and validated on a 30% independent test set to classify the patients based on their microstructural STN signatures. Results: The Random Forest machine learning model achieved an exceptional overall classification accuracy of 93.10% on the test dataset. Receiver Operating Characteristic (ROC) analysis yielded an Area Under the Curve (AUC) of up to 0.938. The performance was perfectly unbiased, with precision, recall, and F1-scores reaching 0.93 for both the surgical and medical cohorts. Feature importance analysis revealed that morphological deformations, specifically STN flatness, and first-order signal intensity drops associated with iron deposition were the most highly discriminative biophysical biomarkers for identifying surgical candidates. Conclusion: The application of machine learning to STN radiomic features provides a highly accurate, non-invasive, and objective methodology to distinguish DBS candidates from medically managed Parkinson's patients. While these findings are promising, prospective and external validation is required before the model can be fully incorporated into routine clinical decision-making.
- 30 September 2026
- Published by Turkish Journal of Clinical Research in Turkish Journal of Clinical Research
- Vol. 2 (2) , 121-127
Open AccessEvaluation of the effects of deep brain neurostimulation in parkinson's patients, analysis of MRI images via artificial intelligence and its use for early diagnosis
Aim: This study aimed to evaluate the early diagnostic potential of subthalamic nucleus (STN) radiomic features and machine learning algorithms to differentiate Parkinson's disease patients requiring Deep Brain Stimulation (DBS) from those managed solely with medical therapy. This approach seeks to provide a non-invasive imaging biomarker to assist in objective surgical decision-making. Methods: A retrospective analysis of 394 Parkinson’s disease patients (200 in the DBS surgical cohort and 194 in the medical treatment cohort) was conducted using preoperative MRI scans. Following meticulous manual segmentation of the STN, a comprehensive set of radiomic features—including shape, first-order statistics, and Gray Level Co-occurrence Matrix (GLCM) parameters—was extracted. A Random Forest classifier was trained on 70% of the dataset and validated on a 30% independent test set to classify the patients based on their microstructural STN signatures. Results: The Random Forest machine learning model achieved an exceptional overall classification accuracy of 93.10% on the test dataset. Receiver Operating Characteristic (ROC) analysis yielded an Area Under the Curve (AUC) of up to 0.938. The performance was perfectly unbiased, with precision, recall, and F1-scores reaching 0.93 for both the surgical and medical cohorts. Feature importance analysis revealed that morphological deformations, specifically STN flatness, and first-order signal intensity drops associated with iron deposition were the most highly discriminative biophysical biomarkers for identifying surgical candidates. Conclusion: The application of machine learning to STN radiomic features provides a highly accurate, non-invasive, and objective methodology to distinguish DBS candidates from medically managed Parkinson's patients. While these findings are promising, prospective and external validation is required before the model can be fully incorporated into routine clinical decision-making.
- Open Access
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 718-729
Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience
Background/aim: This study aimed to evaluate the demographic, clinical, and hormonal characteristics; comorbidities; surgical pathology; treatment modalities; and long-term clinical outcomes of patients diagnosed with and managed for acromegaly at our tertiary referral center over a 15-year period. Materials and methods: Between 2010 and 2024, 247 patients with acromegaly were evaluated. Diagnosis and biochemical remission were determined according to the 2024 Acromegaly Consensus Criteria. Results: The median follow-up duration was 8 years (IQR: 3–14). At the time of diagnosis, the most frequent pituitary hormone deficiency was secondary adrenal insufficiency, present in 17.8% of patients. The most common comorbidities were hypertension (HT, 42.1%) and diabetes mellitus (DM, 30.8%). At the time of diagnosis, macroadenomas were present in 153 of 193 patients (79.3%), and, according to the Knosp classification, 28.6% of tumors were grade 4. A total of 218 patients underwent surgical intervention; 86 (39.4%) achieved postoperative cure without the need for adjuvant medical therapy or radiotherapy. Postoperatively, one or more anterior pituitary hormone deficiencies were found in 34 patients (22.8%), with central hypothyroidism being the most common (52.9%). Patients who achieved biochemical remission were significantly older (p = 0.003), had a higher prevalence of HT and DM (both p < 0.05), and were more likely to exhibit positive growth hormone (GH) immunostaining (p = 0.017). In contrast, those who did not achieve remission were more likely to have higher Knosp grades (3–4) (p = 0.002). Conclusions: In this study, a favorable prognosis was associated with older age at diagnosis, lower baseline GH levels, positive GH immunostaining, smaller tumor size, and lower Knosp grade, underscoring the prognostic value of both biochemical and anatomical parameters. Further studies are warranted to refine prognostic markers and establish standardized treatment algorithms to improve long-term outcomes in acromegaly.
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 718-729
Open AccessClinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience
Background/aim: This study aimed to evaluate the demographic, clinical, and hormonal characteristics; comorbidities; surgical pathology; treatment modalities; and long-term clinical outcomes of patients diagnosed with and managed for acromegaly at our tertiary referral center over a 15-year period. Materials and methods: Between 2010 and 2024, 247 patients with acromegaly were evaluated. Diagnosis and biochemical remission were determined according to the 2024 Acromegaly Consensus Criteria. Results: The median follow-up duration was 8 years (IQR: 3–14). At the time of diagnosis, the most frequent pituitary hormone deficiency was secondary adrenal insufficiency, present in 17.8% of patients. The most common comorbidities were hypertension (HT, 42.1%) and diabetes mellitus (DM, 30.8%). At the time of diagnosis, macroadenomas were present in 153 of 193 patients (79.3%), and, according to the Knosp classification, 28.6% of tumors were grade 4. A total of 218 patients underwent surgical intervention; 86 (39.4%) achieved postoperative cure without the need for adjuvant medical therapy or radiotherapy. Postoperatively, one or more anterior pituitary hormone deficiencies were found in 34 patients (22.8%), with central hypothyroidism being the most common (52.9%). Patients who achieved biochemical remission were significantly older (p = 0.003), had a higher prevalence of HT and DM (both p < 0.05), and were more likely to exhibit positive growth hormone (GH) immunostaining (p = 0.017). In contrast, those who did not achieve remission were more likely to have higher Knosp grades (3–4) (p = 0.002). Conclusions: In this study, a favorable prognosis was associated with older age at diagnosis, lower baseline GH levels, positive GH immunostaining, smaller tumor size, and lower Knosp grade, underscoring the prognostic value of both biochemical and anatomical parameters. Further studies are warranted to refine prognostic markers and establish standardized treatment algorithms to improve long-term outcomes in acromegaly.
- 27 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 188, e25-e33
Neuroprotective Effects of Coenzyme Q10 and Ozone Therapy on Experimental Traumatic Spinal Cord Injuries in Rats
- 27 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 188, e25-e33
Neuroprotective Effects of Coenzyme Q10 and Ozone Therapy on Experimental Traumatic Spinal Cord Injuries in Rats
- 29 September 2023
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 19 (3) , 263-268
Microendoscopic Discectomy for Lumbar Disc Herniations: A Series of 389 Cases
- 29 September 2023
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 19 (3) , 263-268
Microendoscopic Discectomy for Lumbar Disc Herniations: A Series of 389 Cases
- Open Access
- 5 July 2023
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 21, eRC0229
Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism
In this article, we present a case of diffuse follicular variant papillary thyroid carcinoma with pituitary metastasis, which is a rare cause of pituitary metastasis. The follicular variant of papillary thyroid carcinoma is an uncommon variant of papillary carcinoma. A 74-year-old male was presented with weakness, fatigue, and a decreased appetite. The patient was diagnosed with secondary adrenal and thyroid insufficiencies. Imaging revealed a pituitary mass with suprasellar extension, right cavernous sinus invasion, and optic chiasm compression. Thyroid ultrasonography
- 5 July 2023
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 21, eRC0229
Open AccessMetastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism
In this article, we present a case of diffuse follicular variant papillary thyroid carcinoma with pituitary metastasis, which is a rare cause of pituitary metastasis. The follicular variant of papillary thyroid carcinoma is an uncommon variant of papillary carcinoma. A 74-year-old male was presented with weakness, fatigue, and a decreased appetite. The patient was diagnosed with secondary adrenal and thyroid insufficiencies. Imaging revealed a pituitary mass with suprasellar extension, right cavernous sinus invasion, and optic chiasm compression. Thyroid ultrasonography
- 30 December 2022
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 48 (3) , 363-366
Tirotoksikozun Nadir Bir Nedeni: TSH Salgılayan Hipofiz Adenomu
Tiroid stimulan hormon (TSH) salgılayan hipofiz adenomu (TSHoma) tirotoksikozun nadir görülen sebeplerinden biridir. Tanı genellikle uygunsuz TSH yüksekliğinin araştırılması ya da hipofizer insidentalomanın tetkiki sırasında konulmaktadır. Olgumuz bilinen poliskistik over sendromu olan 26 yaşında kadın hasta olup altı aydır olan titreme, terleme ve baş ağrısı yakınmalarıyla kliniğimize başvurdu. Laboratuvar analizlerinde serum serbest T3 ve T4 düzeyi yüksek iken TSH düzeyi normal sınırlarda saptandı. Seks hormonu bağlayıcı globülin (SHBG) düzeyi normal sınırlardaydı Manyetik rezonans görüntüleme sonucunda hipofiz bezinde makradenom izlendi. TRH uyarı testine TSH yanıtı saptanmadı. TSHoma tanısı alan hastada preoperatif oktreotid ve metimazol tedavisi ile ötiroidizm sağlandıktan sonra hipofiz cerrahisi uygulandı. Cerrahi materyalin histopatolojik incelemesinde fibrotik değişikliklerle birlikte prolaktin ile pozitif, TSH ile negatif boyanma izlendi. Bu olgu sunumunda SHBG düzeyi normal ve TSH boyaması negatif olmasına rağmen uygunsuz TSH salınımı nedeniyle TSHoma tanısı alan bir hastayı sunmayı amaçladık.
- 30 December 2022
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 48 (3) , 363-366
Tirotoksikozun Nadir Bir Nedeni: TSH Salgılayan Hipofiz Adenomu
Tiroid stimulan hormon (TSH) salgılayan hipofiz adenomu (TSHoma) tirotoksikozun nadir görülen sebeplerinden biridir. Tanı genellikle uygunsuz TSH yüksekliğinin araştırılması ya da hipofizer insidentalomanın tetkiki sırasında konulmaktadır. Olgumuz bilinen poliskistik over sendromu olan 26 yaşında kadın hasta olup altı aydır olan titreme, terleme ve baş ağrısı yakınmalarıyla kliniğimize başvurdu. Laboratuvar analizlerinde serum serbest T3 ve T4 düzeyi yüksek iken TSH düzeyi normal sınırlarda saptandı. Seks hormonu bağlayıcı globülin (SHBG) düzeyi normal sınırlardaydı Manyetik rezonans görüntüleme sonucunda hipofiz bezinde makradenom izlendi. TRH uyarı testine TSH yanıtı saptanmadı. TSHoma tanısı alan hastada preoperatif oktreotid ve metimazol tedavisi ile ötiroidizm sağlandıktan sonra hipofiz cerrahisi uygulandı. Cerrahi materyalin histopatolojik incelemesinde fibrotik değişikliklerle birlikte prolaktin ile pozitif, TSH ile negatif boyanma izlendi. Bu olgu sunumunda SHBG düzeyi normal ve TSH boyaması negatif olmasına rağmen uygunsuz TSH salınımı nedeniyle TSHoma tanısı alan bir hastayı sunmayı amaçladık.
- 18 May 2022
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 37 (2) , 206-212
Endonasal endoscopic approach for sellar metastatic pathologies: a national observation
Sellar metastases are rare lesions. Recent improvements in diagnosis and treatment strategies have prolonged survival but increased the probability of metastatic tumors. Evaluation with clinical symptomatology and meticulous laboratory examination is crucial. We present our multicenter national study on sellar metastases to evaluate and underline the main clinical, endocrine, and radiological considerations regarding the diagnosis and endonasal endoscopic management of such rare lesions. A medical literature-based retrospective study was planned across 13 neurosurgical centers in Turkey, where a data survey was conducted to collect information regarding sellar metastases surgically treated using the endoscopic endonasal approach, including clinical presentation, radiographic features, primary tumor origin, histopathological confirmation, time to metastasis, treatment, and patient outcomes. Between 2010 and 2020, 54 patients (22 women [40.7%] and 32 men [59.3%]) who underwent surgery with the endonasal endoscopic approach and had pathologically proven sellar metastases (overall incidence, 0.54%) were included. Of the patients, 59.3% had no known malignancy and presented with new-onset symptoms, 79.6% reported headache, 51.9% complained of some degree of visual deficits, and 50% had cranial nerve symptoms. Tissue biopsy was performed in 7.4% of the patients, whereas gross or subtotal resection was achieved in the remaining patients. To our knowledge, this is the largest series of patients surgically treated with the endonasal endoscopic approach for sellar metastases. For these patients, the treatment focus should be on management modalities for increasing quality of life instead radical treatment options with survival benefit.
- 18 May 2022
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 37 (2) , 206-212
Endonasal endoscopic approach for sellar metastatic pathologies: a national observation
Sellar metastases are rare lesions. Recent improvements in diagnosis and treatment strategies have prolonged survival but increased the probability of metastatic tumors. Evaluation with clinical symptomatology and meticulous laboratory examination is crucial. We present our multicenter national study on sellar metastases to evaluate and underline the main clinical, endocrine, and radiological considerations regarding the diagnosis and endonasal endoscopic management of such rare lesions. A medical literature-based retrospective study was planned across 13 neurosurgical centers in Turkey, where a data survey was conducted to collect information regarding sellar metastases surgically treated using the endoscopic endonasal approach, including clinical presentation, radiographic features, primary tumor origin, histopathological confirmation, time to metastasis, treatment, and patient outcomes. Between 2010 and 2020, 54 patients (22 women [40.7%] and 32 men [59.3%]) who underwent surgery with the endonasal endoscopic approach and had pathologically proven sellar metastases (overall incidence, 0.54%) were included. Of the patients, 59.3% had no known malignancy and presented with new-onset symptoms, 79.6% reported headache, 51.9% complained of some degree of visual deficits, and 50% had cranial nerve symptoms. Tissue biopsy was performed in 7.4% of the patients, whereas gross or subtotal resection was achieved in the remaining patients. To our knowledge, this is the largest series of patients surgically treated with the endonasal endoscopic approach for sellar metastases. For these patients, the treatment focus should be on management modalities for increasing quality of life instead radical treatment options with survival benefit.
- Open Access
- 1 January 2021
- Published by ScopeMed in Annals of Medical Research
- Vol. 28 (6) , 1355
Role of NELL2 and LAMA2 immunohistochemistry in the histological classification of ependymomas in adult and pediatric patients
- 1 January 2021
- Published by ScopeMed in Annals of Medical Research
- Vol. 28 (6) , 1355
Open AccessRole of NELL2 and LAMA2 immunohistochemistry in the histological classification of ependymomas in adult and pediatric patients
- Open Access
- 22 July 2018
- Published by Wiley in Parkinson's Disease
- Vol. 2018, 1-7
Experience Reduces Surgical and Hardware-Related Complications of Deep Brain Stimulation Surgery: A Single-Center Study of 181 Patients Operated in Six Years
Objective. Deep brain stimulation (DBS) surgery has increasingly been performed for the treatment of movement disorders and is associated with a wide array of complications. We aimed to present our experience and discuss strategies to minimize adverse events in light of this contemporary series and others in the literature. Methods. A retrospective chart review was conducted to collect data on age, sex, indication, operation date, surgical technique, and perioperative and late complications. Results. A total of 181 patients (113 males, 68 females) underwent DBS implantation surgery (359 leads) in the past six years. Indications and targets were as follows: Parkinson’s disease (STN) (), dystonia (GPi) (), and essential tremor (Vim) (). Mean age was 55.2 ± 11.7 (range 9–74) years. Mean follow-up duration was 3.4 ± 1.6 years. No mortality or permanent morbidity was observed. Major perioperative complications were confusion (6.6%), intracerebral hemorrhage (2.2%), stroke (1.1%), and seizures (1.1%). Long-term adverse events included wound (7.2%), mostly infection, and hardware-related (5.5%) complications. Among several factors, only surgical experience was found to be related with overall complication rates (early period: 31% versus late period: 10%; ). Conclusion. The rates of both early and late complications of DBS surgery are acceptably low and decrease significantly with cumulative experience.- 22 July 2018
- Published by Wiley in Parkinson's Disease
- Vol. 2018, 1-7
Open AccessExperience Reduces Surgical and Hardware-Related Complications of Deep Brain Stimulation Surgery: A Single-Center Study of 181 Patients Operated in Six Years
Objective. Deep brain stimulation (DBS) surgery has increasingly been performed for the treatment of movement disorders and is associated with a wide array of complications. We aimed to present our experience and discuss strategies to minimize adverse events in light of this contemporary series and others in the literature. Methods. A retrospective chart review was conducted to collect data on age, sex, indication, operation date, surgical technique, and perioperative and late complications. Results. A total of 181 patients (113 males, 68 females) underwent DBS implantation surgery (359 leads) in the past six years. Indications and targets were as follows: Parkinson’s disease (STN) (), dystonia (GPi) (), and essential tremor (Vim) (). Mean age was 55.2 ± 11.7 (range 9–74) years. Mean follow-up duration was 3.4 ± 1.6 years. No mortality or permanent morbidity was observed. Major perioperative complications were confusion (6.6%), intracerebral hemorrhage (2.2%), stroke (1.1%), and seizures (1.1%). Long-term adverse events included wound (7.2%), mostly infection, and hardware-related (5.5%) complications. Among several factors, only surgical experience was found to be related with overall complication rates (early period: 31% versus late period: 10%; ). Conclusion. The rates of both early and late complications of DBS surgery are acceptably low and decrease significantly with cumulative experience. - 1 February 2012
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 114 (2) , 196-198
Shunt overdrainage after mild head trauma
- 1 February 2012
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 114 (2) , 196-198
Shunt overdrainage after mild head trauma